VANCOMYCIN vs VEDOLIZUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
VANCOMYCIN vs VEDOLIZUMAB: Safety Overview
| Metric | VANCOMYCIN | VEDOLIZUMAB |
|---|---|---|
| Total FAERS Reports | 33,881 | 73,857 |
| Deaths Reported | 5,348 | 3,476 |
| Death Rate | 15.8% | 4.7% |
| Hospitalizations | 15,776 | 21,677 |
| Average Patient Age | 51.4 yrs | 50.0 yrs |
| % Female Patients | 45.8% | 56.5% |
| FDA Approval Date | Approved Prior to Jan 1, 1982 | N/A |
| Manufacturer | Hikma Pharmaceuticals USA Inc. | Takeda Pharmaceuticals America, Inc. |
| Route | INTRAVENOUS | SUBCUTANEOUS |
| Marketing Status | Prescription | Prescription |